Pyridam Farma Tbk (PYFA) - Total Liabilities
Based on the latest financial reports, Pyridam Farma Tbk (PYFA) has total liabilities worth Rp6.19 Trillion IDR (≈ $362.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pyridam Farma Tbk - Total Liabilities Trend (2001–2024)
This chart illustrates how Pyridam Farma Tbk's total liabilities have evolved over time, based on quarterly financial data. See PYFA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Pyridam Farma Tbk Competitors by Total Liabilities
The table below lists competitors of Pyridam Farma Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Etga Group Ltd
TA:ETGA
|
Israel | ILA809.39 Million |
|
UOA Real Estate Investment Trust
KLSE:5110
|
Malaysia | RM773.78 Million |
|
Benchmark Holdings Plc
LSE:BMK
|
UK | GBX121.45 Million |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$644.32 Million |
|
Bank Capital Indonesia Tbk
JK:BACA
|
Indonesia | Rp19.54 Trillion |
|
RCM Technologies Inc
NASDAQ:RCMT
|
USA | $88.44 Million |
|
Lindsell Train Investment Trust Plc
LSE:LTI
|
UK | £209.00K |
|
Dwi Guna Laksana Tbk PT
JK:DWGL
|
Indonesia | Rp1.66 Trillion |
Liability Composition Analysis (2001–2024)
This chart breaks down Pyridam Farma Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Pyridam Farma Tbk.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.06 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 8.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.89 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pyridam Farma Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pyridam Farma Tbk (2001–2024)
The table below shows the annual total liabilities of Pyridam Farma Tbk from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp4.77 Trillion ≈ $279.59 Million |
+309.87% |
| 2023-12-31 | Rp1.16 Trillion ≈ $68.22 Million |
+7.97% |
| 2022-12-31 | Rp1.08 Trillion ≈ $63.18 Million |
+68.70% |
| 2021-12-31 | Rp639.12 Billion ≈ $37.45 Million |
+800.89% |
| 2020-12-31 | Rp70.94 Billion ≈ $4.16 Million |
+7.39% |
| 2019-12-31 | Rp66.06 Billion ≈ $3.87 Million |
-3.04% |
| 2018-12-31 | Rp68.13 Billion ≈ $3.99 Million |
+34.36% |
| 2017-12-31 | Rp50.71 Billion ≈ $2.97 Million |
-17.62% |
| 2016-12-31 | Rp61.55 Billion ≈ $3.61 Million |
+4.81% |
| 2015-12-31 | Rp58.73 Billion ≈ $3.44 Million |
-22.17% |
| 2014-12-31 | Rp75.46 Billion ≈ $4.42 Million |
-7.09% |
| 2013-12-31 | Rp81.22 Billion ≈ $4.76 Million |
+68.70% |
| 2012-12-31 | Rp48.14 Billion ≈ $2.82 Million |
+35.10% |
| 2011-12-31 | Rp35.64 Billion ≈ $2.09 Million |
+52.54% |
| 2010-12-31 | Rp23.36 Billion ≈ $1.37 Million |
-13.19% |
| 2009-12-31 | Rp26.91 Billion ≈ $1.58 Million |
-8.47% |
| 2008-12-31 | Rp29.40 Billion ≈ $1.72 Million |
+4.21% |
| 2007-12-31 | Rp28.21 Billion ≈ $1.65 Million |
+57.38% |
| 2006-12-31 | Rp17.93 Billion ≈ $1.05 Million |
+37.06% |
| 2005-12-31 | Rp13.08 Billion ≈ $766.41K |
+57.83% |
| 2004-12-31 | Rp8.29 Billion ≈ $485.58K |
+9.67% |
| 2003-12-31 | Rp7.56 Billion ≈ $442.77K |
-21.76% |
| 2002-12-31 | Rp9.66 Billion ≈ $565.95K |
-40.17% |
| 2001-12-31 | Rp16.14 Billion ≈ $945.96K |
-- |
About Pyridam Farma Tbk
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extra… Read more